Article

ARVO announces 2008 Weisenfeld recipient

Fort Lauderdale, FL-George O. Waring III, MD, FACS, FRCOphth, has been selected by the Association for Research in Vision and Ophthalmology (ARVO) to receive the association's 2008 Weisenfeld Award.

Fort Lauderdale, FL-George O. Waring III, MD, FACS, FRCOphth, has been selected by the Association for Research in Vision and Ophthalmology (ARVO) to receive the association's 2008 Weisenfeld Award. This award, which will be presented at ARVO's annual meeting next spring inFort Lauderdale, FL, is given annually for excellence in ophthalmology.

Dr. Waring is being honored with the award for his leadership in the field of refractive surgery and strict enforcement of scientific principles in his groundbreaking work.

In his profession Dr. Waring has won numerous other awards including, three American Academy of Ophthalmology Honor Awards, the Castroviejo Medal from the Corneal Society, and four awards from the International Society of Refractive Surgery, including the Lifetime Achievement Award.

As a 25-year tenured, clinical professor of ophthalmology at Emory University School of Medicine, Dr. Waring has trained around 75 corneal fellows. He is also editor-in-chief of The Journal of Refractive Surgery and founding surgeon at In View Vision Center in Atlanta. He has taught ophthalmology at more than 600 meetings in more than 60 countries on six continents.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.